GO:0047416 arylalkyl acylamidase activity

Arylalkyl acylamidase activity (GO:0047416) is a molecular function that catalyzes the hydrolysis of N-acetylarylalkylamine to yield acetate and the corresponding arylalkylamine. This activity was defined biochemically through the purification and characterization of a novel enzyme, arylalkyl acylamidase, from Pseudomonas putida Sc2, which provided the first direct evidence for this catalytic capability. The term is therefore anchored in a concrete enzymatic reaction rather than a broad pathway annotation, making it a precise target for functional genomics and enzymology studies. For researchers, GO:0047416 matters because it connects a defined chemical transformation to a measurable enzyme activity, enabling hypothesis-driven experiments on substrate specificity, stereochemistry, and cellular roles. The same activity has been exploited in enzymatic asymmetric synthesis, where arylalkyl acylamidases generate alpha-methyl arylalkylamines and alpha-methyl arylalkylalcohols with defined stereochemistry. This dual relevance, basic catalysis plus synthetic utility, makes GO:0047416 a useful node for both mechanistic and applied research.

In plain terms, GO:0047416 describes an enzyme activity that uses water to cut an acetyl group off an N-acetylarylalkylamine, releasing acetate and a free arylalkylamine. The official definition is: Catalysis of the reaction: H2O + N-acetylarylalkylamine = acetate + arylalkylamine. It is classified as a molecular function and is also known by the synonyms aralkyl acylamidase activity and N-acetylarylalkylamine amidohydrolase activity. The reaction is a hydrolytic deacetylation, placing the activity within the amidohydrolase family of enzymes.

GO:0047416 is important because it defines a specific, testable enzymatic activity that bridges enzyme mechanism and chiral amine synthesis. The purification of arylalkyl acylamidase from Pseudomonas putida Sc2 established a biochemical reference point for this activity, allowing researchers to design assays, compare homologs, and assign function to uncharacterized genes. In addition, the ability of arylalkyl acylamidases to catalyze asymmetric synthesis of alpha-methyl arylalkylamines and alpha-methyl arylalkylalcohols links this GO term to stereoselective biocatalysis. For functional genomics, GO:0047416 provides a precise annotation target: a candidate gene can be tested for this activity rather than assigned a vague metabolic role. This precision supports reproducible research across microbiology, enzymology, and synthetic biology.

The genes and proteins most directly associated with GO:0047416 are those encoding arylalkyl acylamidase enzymes and their close functional relatives, as defined by the purified reference enzyme and its synthetic applications.

The provided verified citations do not include specific regulatory mechanisms for arylalkyl acylamidase activity, so regulation is described only at the level supported by the literature: the activity is defined by its catalytic reaction and has been studied through enzyme purification and asymmetric synthesis applications. No transcription factors, signaling pathways, or allosteric regulators for GO:0047416 are documented in the verified sources.

The verified literature on GO:0047416 does not establish a direct link to a specific human disease. The characterized enzyme was purified from Pseudomonas putida Sc2, a bacterial source, and the reported applications concern enzymatic asymmetric synthesis rather than disease mechanisms. Researchers should therefore treat disease associations for this activity as unverified unless supported by additional primary literature.

Although no disease link is documented in the verified citations, arylalkyl acylamidases can synthesize alpha-methyl arylalkylamines and alpha-methyl arylalkylalcohols, which are chiral building blocks of interest in chemical and pharmaceutical research. This makes GO:0047416 relevant to applied biocatalysis rather than to a defined pathology in the available sources.

The reference enzyme for GO:0047416 was isolated from Pseudomonas putida Sc2, placing the activity in a microbial enzymology context. This bacterial origin means that any disease relevance would require additional evidence beyond the verified citations, and no such evidence is provided here.

The foundational method for studying GO:0047416 is purification of the enzyme followed by biochemical characterization, as performed for the arylalkyl acylamidase from Pseudomonas putida Sc2. This approach establishes that a candidate protein carries the activity and defines its basic catalytic properties.

Because the reaction produces acetate and arylalkylamine, activity assays can detect either product to quantify GO:0047416. Such assays are essential for confirming that a gene product catalyzes the defined reaction rather than a related but distinct hydrolysis.

Arylalkyl acylamidases have been applied to enzymatic asymmetric synthesis of alpha-methyl arylalkylamines and alpha-methyl arylalkylalcohols, so stereochemical analysis is a key method for studying this activity. This method reveals whether the enzyme generates products with defined chirality.

Recombinant expression and genetic manipulation allow researchers to test whether a specific gene is necessary and sufficient for GO:0047416. Combining knockout, point mutation, and overexpression models provides causal evidence linking genotype to enzyme activity.

Researchers studying arylalkyl acylamidase activity-related genes often need to determine whether a candidate gene is causally involved in the defined hydrolytic reaction, and CRISPR-based models provide a rigorous way to test necessity, sufficiency, and mechanism.

GO:0047416 arylalkyl acylamidase activity is a precisely defined molecular function catalyzing the hydrolysis of N-acetylarylalkylamine to acetate and arylalkylamine. Its biochemical foundation comes from the purification and characterization of arylalkyl acylamidase from Pseudomonas putida Sc2, and its applied relevance is demonstrated by asymmetric synthesis of chiral amines and alcohols. For researchers, the term offers a clear experimental target that can be interrogated with enzyme assays and CRISPR-based genetic models.